Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease

Identifieur interne : 003513 ( Main/Exploration ); précédent : 003512; suivant : 003514

Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease

Auteurs : Lauren H. Craig [États-Unis] ; Anna Svircev [États-Unis] ; Michael Haber [États-Unis] ; Jorge L. Juncos [États-Unis]

Source :

RBID : ISTEX:C30074C8FAF92F5B21F30F2B2C4EFF41A3EFFFD5

Descripteurs français

English descriptors

Abstract

The objectives of this study is to examine the effects of neuromuscular therapy (NMT) on motor and nonmotor symptoms in Parkinson's disease (PD). Thirty‐six subjects with PD were randomly assigned to NMT or music relaxation (MR, or active control). Subjects received treatment twice a week for 4 weeks. Testing was conducted at baseline, after final treatment, and 8 days after final treatment. Primary outcome measures were the Motor subscale of the United Parkinson Disease Rating Scale (UPDRS) and the Clinical Global Impression scale (CGI‐Change). Secondary outcome measures included a PD‐specific quality of life scale (PDQ‐39), quantitative measures of motor function, and severity scales for anxiety and depression symptoms. NMT resulted in a significant and sustained improvement in the Motor subscale of the UPDRS (P ≤ 0.0001), most notable in the tremor scores. Also improved 1 week after the last treatment were the CGI scores (P = 0.007) and the finger‐tapping speed (P = 0.001). The MR active control group had a slight improvement in tremor but evidenced no other change in motor function. Both groups exhibited a modest improvement in quality of life immediately after the last treatment. This effect was sustained for 8 days only in the MR group. In the nonmotor domains, the MR group evidenced improvements in mood (P = 0.001) and anxiety (P = 0.002), whereas NMT had no effect on mood (P = 0.09), and its initial effect on anxiety (P = 0.0009) dissipated after 8 days (P = 0.40). Group differences for UPDRS motor score and patient CGI‐Change were superior in the NMT compared to the MR group. There was no group difference in PDQ‐39 scores or in nonmotor measures. The findings suggest that NMT can improve motor and selected nonmotor symptoms in PD and that this effect is more durable for the motor symptoms. The results of this pilot study warrant larger controlled studies to examine dose range, durability, and mechanisms of NMT in PD function. © 2006 Movement Disorder Society

Url:
DOI: 10.1002/mds.21132


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease</title>
<author>
<name sortKey="Craig, Lauren H" sort="Craig, Lauren H" uniqKey="Craig L" first="Lauren H." last="Craig">Lauren H. Craig</name>
</author>
<author>
<name sortKey="Svircev, Anna" sort="Svircev, Anna" uniqKey="Svircev A" first="Anna" last="Svircev">Anna Svircev</name>
</author>
<author>
<name sortKey="Haber, Michael" sort="Haber, Michael" uniqKey="Haber M" first="Michael" last="Haber">Michael Haber</name>
</author>
<author>
<name sortKey="Juncos, Jorge L" sort="Juncos, Jorge L" uniqKey="Juncos J" first="Jorge L." last="Juncos">Jorge L. Juncos</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C30074C8FAF92F5B21F30F2B2C4EFF41A3EFFFD5</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/mds.21132</idno>
<idno type="url">https://api.istex.fr/document/C30074C8FAF92F5B21F30F2B2C4EFF41A3EFFFD5/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000584</idno>
<idno type="wicri:Area/Istex/Curation">000584</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F73</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Craig L:controlled:pilot:study</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:17044088</idno>
<idno type="wicri:Area/PubMed/Corpus">002A41</idno>
<idno type="wicri:Area/PubMed/Curation">002A41</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002E02</idno>
<idno type="wicri:Area/Ncbi/Merge">001898</idno>
<idno type="wicri:Area/Ncbi/Curation">001898</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001898</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Craig L:controlled:pilot:study</idno>
<idno type="wicri:Area/Main/Merge">004827</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:07-0090865</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001874</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001447</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001B66</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Craig L:controlled:pilot:study</idno>
<idno type="wicri:Area/Main/Merge">004C61</idno>
<idno type="wicri:Area/Main/Curation">003513</idno>
<idno type="wicri:Area/Main/Exploration">003513</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease</title>
<author>
<name sortKey="Craig, Lauren H" sort="Craig, Lauren H" uniqKey="Craig L" first="Lauren H." last="Craig">Lauren H. Craig</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Atlanta School of Massage, Atlanta, Georgia</wicri:regionArea>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Svircev, Anna" sort="Svircev, Anna" uniqKey="Svircev A" first="Anna" last="Svircev">Anna Svircev</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Atlanta School of Massage, Atlanta, Georgia</wicri:regionArea>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Emory University, Rollins School of Public Health, Atlanta, Georgia</wicri:regionArea>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Haber, Michael" sort="Haber, Michael" uniqKey="Haber M" first="Michael" last="Haber">Michael Haber</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Emory University School of Public Health, Department of Biostatistics, Atlanta, Georgia</wicri:regionArea>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Juncos, Jorge L" sort="Juncos, Jorge L" uniqKey="Juncos J" first="Jorge L." last="Juncos">Jorge L. Juncos</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Emory University School of Medicine, Department of Neurology Movement Disorders Program, Atlanta, Georgia</wicri:regionArea>
<placeName>
<region type="state">Géorgie (États-Unis)</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-12">2006-12</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="2127">2127</biblScope>
<biblScope unit="page" to="2133">2133</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C30074C8FAF92F5B21F30F2B2C4EFF41A3EFFFD5</idno>
<idno type="DOI">10.1002/mds.21132</idno>
<idno type="ArticleID">MDS21132</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Affect (physiology)</term>
<term>Aged</term>
<term>Alternative medicine</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Hypokinesia (etiology)</term>
<term>Hypokinesia (therapy)</term>
<term>Male</term>
<term>Massage</term>
<term>Middle Aged</term>
<term>Muscle Relaxation</term>
<term>Music</term>
<term>Music Therapy (methods)</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson Disease (psychology)</term>
<term>Parkinson Disease (therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Pilot Projects</term>
<term>Prospective Studies</term>
<term>Psychomotor Performance (physiology)</term>
<term>Quality of Life</term>
<term>Questionnaires</term>
<term>Relaxation</term>
<term>Severity of Illness Index</term>
<term>Single-Blind Method</term>
<term>Time Factors</term>
<term>Treatment</term>
<term>Tremor (etiology)</term>
<term>Tremor (therapy)</term>
<term>complementary and alternative medicine</term>
<term>massage therapy</term>
<term>music relaxation</term>
<term>neuromuscular therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Hypokinesia</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Music Therapy</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Affect</term>
<term>Psychomotor Performance</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Hypokinesia</term>
<term>Parkinson Disease</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Muscle Relaxation</term>
<term>Pilot Projects</term>
<term>Prospective Studies</term>
<term>Quality of Life</term>
<term>Questionnaires</term>
<term>Severity of Illness Index</term>
<term>Single-Blind Method</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Homme</term>
<term>Massage</term>
<term>Musique</term>
<term>Médecine parallèle</term>
<term>Parkinson maladie</term>
<term>Relaxation</term>
<term>Système nerveux pathologie</term>
<term>Traitement</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Homme</term>
<term>Musique</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The objectives of this study is to examine the effects of neuromuscular therapy (NMT) on motor and nonmotor symptoms in Parkinson's disease (PD). Thirty‐six subjects with PD were randomly assigned to NMT or music relaxation (MR, or active control). Subjects received treatment twice a week for 4 weeks. Testing was conducted at baseline, after final treatment, and 8 days after final treatment. Primary outcome measures were the Motor subscale of the United Parkinson Disease Rating Scale (UPDRS) and the Clinical Global Impression scale (CGI‐Change). Secondary outcome measures included a PD‐specific quality of life scale (PDQ‐39), quantitative measures of motor function, and severity scales for anxiety and depression symptoms. NMT resulted in a significant and sustained improvement in the Motor subscale of the UPDRS (P ≤ 0.0001), most notable in the tremor scores. Also improved 1 week after the last treatment were the CGI scores (P = 0.007) and the finger‐tapping speed (P = 0.001). The MR active control group had a slight improvement in tremor but evidenced no other change in motor function. Both groups exhibited a modest improvement in quality of life immediately after the last treatment. This effect was sustained for 8 days only in the MR group. In the nonmotor domains, the MR group evidenced improvements in mood (P = 0.001) and anxiety (P = 0.002), whereas NMT had no effect on mood (P = 0.09), and its initial effect on anxiety (P = 0.0009) dissipated after 8 days (P = 0.40). Group differences for UPDRS motor score and patient CGI‐Change were superior in the NMT compared to the MR group. There was no group difference in PDQ‐39 scores or in nonmotor measures. The findings suggest that NMT can improve motor and selected nonmotor symptoms in PD and that this effect is more durable for the motor symptoms. The results of this pilot study warrant larger controlled studies to examine dose range, durability, and mechanisms of NMT in PD function. © 2006 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Géorgie (États-Unis)</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Géorgie (États-Unis)">
<name sortKey="Craig, Lauren H" sort="Craig, Lauren H" uniqKey="Craig L" first="Lauren H." last="Craig">Lauren H. Craig</name>
</region>
<name sortKey="Haber, Michael" sort="Haber, Michael" uniqKey="Haber M" first="Michael" last="Haber">Michael Haber</name>
<name sortKey="Juncos, Jorge L" sort="Juncos, Jorge L" uniqKey="Juncos J" first="Jorge L." last="Juncos">Jorge L. Juncos</name>
<name sortKey="Svircev, Anna" sort="Svircev, Anna" uniqKey="Svircev A" first="Anna" last="Svircev">Anna Svircev</name>
<name sortKey="Svircev, Anna" sort="Svircev, Anna" uniqKey="Svircev A" first="Anna" last="Svircev">Anna Svircev</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003513 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003513 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:C30074C8FAF92F5B21F30F2B2C4EFF41A3EFFFD5
   |texte=   Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024